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Medication non-adherence can cause impairments that 
interfere with self-care activities in individuals who suffer from 
multiple comorbid diseases that require careful management. The 
objective of this study is to assess and describe medication 
adherence in patients of Aseer Region of Kingdom of Saudi Arabia 
(KSA). Samples of 416 patients in the outpatient department at 
Abha General Hospital and Aseer Central Hospital are selected 
randomly. The patients were interviewed using seven a self-
administered close-ended anonymous questionnaire. Only 
descriptive statistics is reported in this study for analyze the 
compliance category. The participants in the study were 71% (295 
out of 416 patients) of participants were females, while 29% (121 
out of 416) were males. The participants’ age ranges between 18-
60 years. The adherence level was 85%. The major reasons for 
non-adherence were forgetfulness and feeling good. The study 
revealed the appropriate level of adherence by participants. The 
study also revealed that pharmacists and other healthcare 
professional intervention will help to improve further the 
medication adherence with possible fruitful therapeutic outcomes 
of the patients. 
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INTRODUCTION 
Around a quarter of patients do not take 
their medicines as prescribed (Elliott et al., 
2008). Non-compliance with medication means 
failure on the part of a client to follow the 
recommendations of a health professional with 
regards to their medication, However modern 
health care is concerned with working with 
clients and has therefore suggested that 
‘concordance’ should replace the use of the 
word ‘compliance’. Concordance projects 
patient rights, needs for information, the 
importance of two-way communication and 
decision-making such as stopping medication 
even if clinicians do not agree with the decision 
(Gray et al., 2002). The significance of the 
problem is indicated in statistics showing that 
up to half of all patients fail to follow their 
prescribed drug regimens (Barbara Worsley, 
Vice President, Risk Management, The SCPIE 
Companies 2014). A vast amount of research 
has explored its causes, and numerous factors 
related to the patient, disease, treatment, health 
care provider and health care system are known 
to be associated with adherence (Alakhali et al., 
2013, Dodd et al., 2012). The World Health 
Organization (WHO) categorized the 
determinants of non-adherence into five 
dimensions: social and economic, health 
system-related, therapy related, condition-
related, and patient-related (Hovstadius et al., 
2011). Research over the past 2 decades has 
consistently shown that intentional non-
adherence is driven by patient beliefs about 
their treatment, disease, and prognosis as well 
as their objective experiences with medications. 
Some early research on unintentional non-
adherence suggested it was more strongly 
correlated with demographic characteristics 
than with medication knowledge or beliefs 
(Gadkari et al., 2012). When looking specifically 
at the management of certain chronic medical 
conditions such as diabetes, hypertension and 
dyslipidemia, nearly one out of every three 
patients was primarily non-adherent (Fallis et 
al., 2013). Despite these insights, thus far there 
remains little consensus on standardized and 
practical approaches for assessing medication 
non-adherence. In part this is due to the lack of 
reliable, validated measurement methods that 
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are useful in both research and clinical settings. 
Currently, the most commonly used 
approaches include self-report, pill counts, 
biological drug levels, pharmacy refill data, and 
electronic pill bottles, each of which has short-
comings (Ye et al., 2012). Thus improving 
adherence enhances patients’ safety. It is crucial 
for health professionals both to assess the 
patient and foresee the possible causes of non-
adherence and follow a policy for increasing 
medication adherence and achieving the best 
health outcome (Kalogianni et al., 2011). 
However the paucity of data about the non-
compliance of patients regarding the 
medication use has prompted us to evaluate the 
reasons of non-compliance of patients in Aseer 
region of Kingdom of Saudi Arabia. The 
objective of this study is to assess and describe 
medication adherence in patients of Aseer 
Region of Kingdom of Saudi Arabia (KSA).   
 
MATERIAL AND METHODS 
The total number of patients is 416.  The 
study is conducted in the outpatient 
department at Abha General Hospital and 
Aseer Central Hospital, KSA, for a period of 4 
months (July to October, 2014). The included 
patients were above 18 years and those below 
the age of 18 years old were excluded.  Data 
analysis was carried out using Microsoft excel. 
Data were expressed as mean (standard 
deviation) for continuous variables and as 
frequency for categorical variables. Only 
descriptive statistics is reported (means with 
95% confidence intervals). 
An anonymous hand written 
questionnaire was administered to 416 patients 
of different age groups in both Abha General 
Hospital and Aseer central hospital. The 
questionnaire comprised 7 items and the 
patients were required to select one or more of 
the reasons of non-adherence.  
 
RESULTS AND DISCUSSION 
Seventy one percent (295 out of 416 
patients) of participants were females, while 
29% (121 out of 416) were males. The 
distribution pattern of diseases among the 
participants (Table I). Grouping adherence 
levels, just 33 percent earn an A grade for being 
completely adherent, additional 52 percent are 
somewhat non-adherent (a grade of B) and the 
remaining 15 percent are largely non-adherent 
(a grade of C) (Table II). In the general 
population, the principal reasons for non-
adherence seem to be the reasons described in 
Table 3. Majority of the participants is totally 
aware or just aware of the consequences of 
non-adherence described in Table 4. Adherence 
is defined as the extent to which a patient’s 
behaviour or action coincides with the advice 
received (Wroth et al., 2006). The results of this 
study indicate that, as elsewhere in the world, 
there is a problem of non-adherence to 
medication among patients with in Aseer region 
of Saudi Arabia. Respondents’ ages ranged 
from 18-60 years. The majority of the 
participants were within the age group 18-28 
years. The characteristics of the diseases among 
the participants were as described in the Table 
1. 38 (9.1%) of the patients were hypertensive 
and diabetic, 15 (3.6%) had heart diseases, 75 
(18%) pulmonary diseases, fractures and bone 
disease 42 (10.1%), 109 (26.2%) had internal 
diseases and 137 (32.9%) had other diseases. 
The reasons reported by patients for non-
adherence to their medication varied across 
the individual, but the  most frequently reported 
reasons were forgetfulness 190 patients (32%). 
This problem of forgetfulness can be resolved 
by using tools like medication reminder or dairy 
keeping. Eighty patients (13%) of the patients 
reported that fear of side effects was the undue 
cause for non adherence. This can be solved by 
bringing to the doctor's attention any 
discomforts they are having, the doctor may 
change the medication or the dosage, prescribe 
another medication to counteract side effects, 
or offer practical suggestions for alleviating the 
discomforts. Fifty one patients (9%) of the 
patients have reported the high cost of 
medication as the reason for non-adherence to 
use of medicines. These results are in 
agreement with the previous results (Ih Eze et 
al., 2011). This problem can be resolved by 
switching brand name medications to generic 
or cheaper alternatives. Reviewing the regimen 
for medications that may no longer be 
necessary can streamline the regimen for ease 
and cost purposes (Latif and Mcnicoll, 2009). 
Use of multiple medications (polypharmacy) is 
associated with an increased risk of complex 
dosing schemes (Hugtenburg et al., 2013).  
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This also has been reported in our study as one 
of the reasons for non-adherence by 60 patients 
(10%). However patient must be educated 
about the need to manage potential drug-drug 
interactions which may also result in complex 
dosing schemes. Medications with a convenient 
way of administration (eg, oral medication) are 
likely to make patients compliant (Jin et al., 
2008).  However 23 (4%) of the patients in our 
study complained that difficulty in using the 
medicine by the method described, (for 
example the use of inhalers in asthma cases), 
was also one of the reasons for non-adherence 
and the results are in agreement with previous 
studies (Al-Jahdali et al., 2013). Intentional non-
adherence (not taking medications when feeling 
better or worse) accounted to 109 (18%) and 85 
(14%) in our study. 
Thirty three percent (33%) of the 
patients mentioned that they are always 
adherent; 52 % patients were sometimes 
adherent while taking medicines and around 
15% were rarely adherent. Overall around 85% 
of the patients were fairly adherent while taking 
medicines and this result is in agreement with 
the previous studies (Okoro and Ngong, 2012).  
Respondents attitude towards awareness 
of consequences of non-adherence showed  
that 44% of the patients were totally aware             
of the consequences of the missed doses,          
42% were little aware and 14% were not aware 
of   the  consequences  of the non-adherence to  
Tabel  I. Patient Characteristics Table: 1 Diseases among the participants' patients in Aseer region 
  
SI.No Disease Count % 
1 HTN & Diabetes 38 9.1% 
2 Heart Disease 15 3.6% 
3 Pulmonary Disease 75 18% 
4 Fractures & bone disease 42 10.1% 
5 Internal Diseases 109 26.2% 
6 Others 137 32.9% 
 
Table: 2 Patient adherences to medications in Aseer region 
 
Adherence Count % Grade 
Always 135 33% A 
Sometimes 217 52% B 
Rarely 64 15% C 
 
Table 3: Distribution of causes for patient non-compliance in Aseer region 
 
SI.No Reason Count % 
1 Difficult method of use  23 4% 
2 High cost and not accessible 51 9% 
3 A lot of medicines daily 60 10% 
4 Side effects or fear of side effects 80 13% 
5 Not feeling better with medicine 85 14% 
6 Feeling good, so why take medicine? 109 18% 
7 Underestimation of consequences, and forgetting 190 32% 
 
Table: 4: Awareness of consequences of non-adherence in Aseer region  
  
State Count % 
Totally Aware 184 44% 
Little Aware 175 42% 
Not Aware 57 14% 
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medication regimen. However in our study we 
did not record what action was taken by the 
patients towards the missed does being aware 
of the consequences of non-adherence. The 
positive attitude towards the missed does will 
enhance adherence. Therefore, noncompliance 
with medication regimens can result in the 
increased use of medical resources such as 
nursing homes, hospitals, physician visits, and 
unnecessary treatment. Noncompliance with 
medication regimens may also result in 
therapeutic failure (Alakhali et al., 2013). For 
example, missed doses of hypertension, 
diabetes and heart disease can make patients 
worse. Further studies for longer time period 
and with a larger patient number are 
recommended to have more definite 
conclusions and to determine the extent and 
outcome of reasons for non-compliance in 




Non-compliance with medication is a 
complex and multidimensional health care 
problem. Patient education is the only way to 
improve compliance. Pharmacist’s and health 
care professionals should enhance medication 
adherence and outcomes by engaging in 
pharmaceutical care activities such as 
monitoring symptoms, providing medication 
counseling, helping resolve drug-related 
problems, and facilitating communication with 
physicians.   
 
ACKNOWLEDGMENT 
We are thankful to the Department of 
Clinical Pharmacy, College of Pharmacy, King 
Khalid University for providing the support for 
this research work  
 
REFERENCES 
Al-Jahdali H., Ahmed A., Al-Harbi A., Khan 
M., Baharoon S., Bin SS., Halwani 
R., Al-Muhsen S., 2013. Improper 
inhaler technique is associated with poor 
asthma control and frequent emergency 
department visits. Allergy Asthma Clin 
Immunol 9, 8.  
Barbara W., Vice P., Risk M., 2014. The SCPIE 
Companies. Noncompliance: A Problem 
for Patients and Doctors  
https://www.scpcf.com/ PDF/MLM-
Noncompliance.pdf (Accessed 8 March) 
Dodd S., White IR., Williamson P., 2012. 
Nonadherence to treatment protocol in 
published randomized controlled trials: a 
review. Trials 18, 13-84.    
Elliott RA., Shinogle JA., Peele P., Bhosle 
M., Hughes DA., 2008. Understanding 
medication compliance and persistence 
from an economic perspective. Value 
Health 11, 600-610. 
Fallis BA., Dhalla IA., Klemensberg J., Bell 
CM., 2013. Primary medication non-
adherence after discharge from a general 
internal medicine service. Plos One 8, 
e61735. 
Gadkari AS., McHorney CA., 2012 Uninten-
tional non-adherence to chronic 
prescripition medications: how 
unintentional is it really? BMC Health 
Serv Res 12, 98. 
Gray R., Wykes T., Gournay K., 2002. 
From compliance to concordance: 
a review the literature 
on interventions to enhance compliance 
with antipsychotic medication. J Psychiatr 
Ment Health Nurs 9, 277-284. 
Hovstadius B., Petersson G., 2011 Non-
adherence to drug therapy and drug 
acquisition costs in a national 
population--a patient-based register 
study. BMC Health Serv Res 11, 326. 
Hugtenburg JG,,  Timmers L.,  Elders PJ.,   
Vervloet M., van Dijk L., 2013. 
Definitions, variants, and causes of 
nonadherence with medication: a 
challenge for tailored interventions. 
Patient Prefer Adherence 7, 675-682. 
Ih Eze U., Ojieabu WA., Femi-Oyewo MN., 
Martins OO., 2011 Evaluation of 
Adherence in Elderly Diabetic 
Hypertensive Patients. IJPI’s Journal of 
Hospital and Clinical Pharmacy 1, 38-46. 
Jin J., Sklar GE., Min SOV., Chuen LS., 2008. 
Factors affecting therapeutics 
compliance: A review from the patients’s 
perspective. Ther Clin Risk Manag  4, 269-
289. 
Alakhali KM., Daniel PS., Noohu AM., 
Sirajudeen SA.., 2013. Patient medication 
adherence and physician prescribing 
Description of Patients' Complianc 
Volume 26 Issue 4 (2015) 232 
among congestive heart failure patients 
of Yemen. Indian J. Pharm. Sci. 75 (5): 
557-562.  
Kalogianni A., 2011 Factors affect in patient 
adherence to medication regimen. Health 
Sci. J. 5, 157-158. 
Latif S., McNicoll L., 2009. Medication and 
non-adherence in the older adult. Rhode 
Island Medical Journal 92, 418-419. 
Okoro RN., Ngong CK., 2012. Assessment of 
patient’s antihypertensive medication 
adherence level in non-comorbid 
hypertension in a tertiary hospital in 
Nigeria. Int J Pharm Biomed Sci 3, 47-54. 
Wroth THR., Pathman DE., 2006. Primary 
medication adherence in a rural 
population: the role of the patients-
physician relationship and satisfaction 
with care. J Am Board Fam Med 19, 478-
486.  
Ye S., Krupka DJ., Davidson KW., 2012. 
Diagnosing medication non-adherence in 
a patient with myocardial infarction. 
Front Psychol 3, 267.  
 
